Wird aktualisiert
Aktuelle Folge
How Matthew Might Is Using Computation to Fight Rare Diseases

How Matthew Might Is Using Computation to Fight Rare Diseases

Harry's guest this week is Matthew Might, director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham. Might trained as a computer scientist, but a personal odyssey inspired him to make the switch into precision med
Länge: 48:33
Harry's guest this week is Matthew Might, director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham. Might trained as a computer scientist, but a personal odyssey inspired him to make the switch into precision medicine. Now he uses computational tools such as knowledge graphs and natural language processing to find existing drug compounds that might help cure people with rare genetic disorders.
Folgen-ID: 1000535282060
GUID: 07ae466a-4d8a-4bae-88b0-fb8ac4e0450a
Erscheinungs­datum: 14.9.2021, 13:00:00

Beschreibung

The power of data is remaking everything in healthcare—not just the way doctors diagnose patients, but the way pharma companies develop drugs and the way hospitals and insurers control costs and create value. Here at MoneyBall Medicine, host Harry Glorikian talks with the executives, entrepreneurs, physicians, and scientists who are pushing that high-tech revolution forward. Harry's 2017 book "MoneyBall Medicine" offered an inside look at the ways genomics, machine learning, and other trends are improving healthcare delivery and efficiency. And now he brings you intimate conversations with industry pioneers—like Mount Sinai's Joel Dudley, N-of-One's Jennifer Carter, Semeion's Massimo Buscema, Genetic Alliance's Sharon Terry, and many more—who share their hard-won experience in the surprising, exciting, untamed world of data-driven healthcare.

Apple Podcasts: Kundenrezensionen

Kein Eintrag